Deltec Asset Management LLC Global Blood Therapeutics, Inc. Transaction History

Deltec Asset Management LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 15, 2021	SELL	$32.46 - $43.42 $973,800 - $1.3 Million	-30,000 Closed	0 $0
Q1 2021 Apr 21, 2021	SELL	$38.94 - $50.85 $2.24 Million - $2.93 Million	-57,552 Reduced 65.73%	30,000 $1.22 Million
Q4 2020 Jan 20, 2021	BUY	$37.65 - $63.77 $3.3 Million - $5.58 Million	87,552 New	87,552 $3.79 Million

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Deltec Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Deltec Asset Management LLC with notifications on news.